VACCINE NEWS

Third Doses for Moderately and Severely Immunocompromised People
On August 13th the CDC’s Advisory Committee on Immunization Practices (ACIP) voted unanimously to recommend an additional dose of the Pfizer vaccine for those 12 and older and of the Moderna vaccine for those 18 and older following a primary series in immunocompromised people. The ACIP took the vote after reaching the conclusion that the desirable consequences of the third dose for this population “clearly outweigh undesirable consequences in most settings.” The ACIP recommendations allow self-attesting moderately and severely immunocompromised people to receive a third dose. People will not need a prescription or a doctor’s signature to receive a third dose. As for the rollout of this decision, CDC staff said they have been working with pharmacies to be prepared should the Committee vote positively and the CDC is hoping these third doses can be rapidly implemented. An article about the ACIP’s decision is here.

Third Doses / Changes to Weekly NHSN COVID-19 Vaccination Data Collection Forms.
Following the August 13th ACIP recommendation for additional vaccine series for moderately and severely immunocompromised people, the CDC has announced new questions on vaccine doses will be added to the data collection forms. The main changes are: Question #2 remains the same, except it asks about the primary vaccination series; Added question #4 for facilities to report on the cumulative number of individuals eligible to receive an additional dose of COVID-19 vaccine. Added question #5 for facilities to report on the cumulative number of individuals who received an additional dose of COVID-19 vaccine (by manufacturer type). The CDC will be conducting training webinars in late August.

Payment for COVID-19 Vaccine Additional Dose
Medicare stands ready to pay for administering an additional dose of COVID-19 vaccine consistent with the FDA emergency use authorization (EUA). They will pay the same amount to administer this additional dose as they did for other doses of the COVID-19 vaccine (approximately $40 each). More information in the coming days about billing and coding.

For more information:

LEADINGAGE KANSAS NEWS

Want to Stay in the Know and Get the Latest Info?
Make plans to join us each Friday at 10 AM. Register here. Let Nicole know if you have specific topics we should add to the agenda.

LEADINGAGE NATIONAL NEWS

Provider Relief Fund Webinar Recording Now Available.
If you missed the LeadingAge “Complying with the New Provider Relief Fund Reporting Requirements” webinar on July 27th, you can still access it here. It walks through step-by-step what providers need to know, where the risks may be and includes 45-minutes of Q &A to help members understand what they need to report. The first report is due September 30th.

New Insights and Tools from LeadingAge
LeadingAge staff experts are developing essential advocacy, guidance, and tools, and curating the most relevant resources for aging services providers, including: 

THANK YOU TO OUR GOLD PARTNER

Previous articleCOVID-19/Novel Coronavirus Update for 8-13-2021
Next articleNursing Home Salary and Benefits Report
Avatar photo
Nicole Schings is the Director of Member Services and Business Development. Nicole joined the association in 2018, and oversees our Member Services program, our Partnership and Associate Member relationships, and our online education system. A graduate of Washburn University, Nicole uses her 22 years of experience in the association world to enhance the support of our members, problem solve their issues and bring new partners into the LeadingAge Kansas family. Outside of work, Nicole is passionate about geocaching and moments spent with her dog, Blu. You can reach Nicole directly at 785.670.8048.